Skip to content

Bicara Therapeutics BCAX Permanent differences

Permanent differences at other companies

Cinemark Holdings logo
Cinemark HoldingsCNK
$1.85M+8.8%
Construction Partners logo
Construction PartnersROAD
$625.75K+155%
Ivanhoe Electric logo
Ivanhoe ElectricIE
$860K-13.2%
Ivanhoe Electric logo
Ivanhoe ElectricIE
-3%0.0pp
ACM Research logo
ACM ResearchACMR
0.1%
SBA Communications logo
SBA CommunicationsSBAC
$3.22M+8.4%

Other financials

Income statement

See full
Operating income-$60.2M-44.2%
Net income-$56.2M-52.6%
EPS (diluted)-$0.93-36.8%

Balance sheet

See full
Cash & equivalents$323.5M-30.0%
Total debt$1.4M+144%
Total equity$514.0M+12.0%
Total assets$553.6M+15.8%

Cash flow

See full
Operating cash flow-$37.5M-33.5%
CapEx$60.0K
Free cash flow-$37.6M-33.7%

Valuation

See full
Market cap$1.68B+81.4%

Returns & leverage

See full
Return on equity-32.3%
Debt / equity0.0×
Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept bcax:EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent.

The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's permanent differences.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bicara Therapeutics's permanent differences?
Bicara Therapeutics (BCAX) reported permanent differences of -0.5% in Q4 2024.
What does permanent differences mean?
This metric identifies the impact of permanent differences between financial reporting income and taxable income that will not reverse in future periods. These differences arise from specific accounting treatments or tax regulations that do not align with GAAP. It is essential for understanding the structural gap between the statutory tax rate and the actual effective tax rate.